Medical devices, healthcare technology and the business of care
510(k) clearance · K261624

Omnifit 20° Series I Insert;Omnifit Crossfire 10° Series II Insert; Constrained Acetabular Insert; Trident Crossfire 0° Polyethylene Insert; Trident Crossfire 10° Polyethylene Insert;System 12 Crossfire 10° Insert; Trident 0° Constrained Acetabular Insert; Trident Constrained Acetabular Liner;Trident All Poly Constrained Acetabular Insert; Crossfire Eccentric Insert 10°; Artisan Bone Plug;UHR Universal Head Bipolar Component

Howmedica Osteonics Corp. dba Stryker Orthopaedics · Decision date Jul 10, 2026

FDA DECISIONK261624

What did the FDA decide?

FDA records K261624 as a 510(k) premarket notification, with a decision dated Jul 10, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Orthopedic
Decision date
Jul 10, 2026

FDA source record

Regulatory record facts

Identifier
K261624
Regulatory pathway
510(k) premarket notification
Product code
LPH
Decision code
SESE
Decision date
Jul 10, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Prosthesis, Hip, Semi-Constrained, Metal/Polymer, Porous Uncemented.

Product code
LPH
FDA device class
2

FDA decision timeline

  1. K261624 received

    Application receipt date recorded by FDA.

  2. K261624 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code LPH

Product / regulatory recordCompanyPathwayDecision dateSource
Zimmer Biomet510(k) clearanceSep 23, 2026FDA
Medacta International S.A.510(k) clearanceAug 28, 2026FDA
GLOBUS MEDICAL, INC.510(k) clearanceAug 4, 2026FDA
Nextstep Arthopedix, LLC510(k) clearanceJun 5, 2026FDA
BIOMET, INC.510(k) clearanceMay 19, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Howmedica Osteonics Corp. dba Stryker Orthopaedics

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Mahwah, NJ

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records